Cidara Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cidara Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Cidara Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 150 %, a 6.33% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 150 +8.95 +6.33% Jun 30, 2024
Q1 2024 100 -28.3 -22% Mar 31, 2024
Q4 2023 125 +7.32 +6.24% Dec 31, 2023
Q3 2023 134 -5.53 -3.97% Sep 30, 2023
Q2 2023 141 +3.1 +2.24% Jun 30, 2023
Q1 2023 129 -34.6 -21.2% Mar 31, 2023
Q4 2022 117 -46.3 -28.3% Dec 31, 2022
Q3 2022 139 -9.28 -6.24% Sep 30, 2022
Q2 2022 138 -18.8 -12% Jun 30, 2022
Q1 2022 163 -2.46 -1.48% Mar 31, 2022
Q4 2021 164 -36.9 -18.4% Dec 31, 2021
Q3 2021 149 -72.2 -32.7% Sep 30, 2021
Q2 2021 157 -82 -34.3% Jun 30, 2021
Q1 2021 166 -81.1 -32.9% Mar 31, 2021
Q4 2020 201 -52.6 -20.8% Dec 31, 2020
Q3 2020 221 -74.3 -25.2% Sep 30, 2020
Q2 2020 239 -151 -38.8% Jun 30, 2020
Q1 2020 247 -252 -50.5% Mar 31, 2020
Q4 2019 253 -321 -55.9% Dec 31, 2019
Q3 2019 295 -366 -55.4% Sep 30, 2019
Q2 2019 391 -286 -42.3% Jun 30, 2019
Q1 2019 499 -184 -27% Mar 31, 2019
Q4 2018 575 -249 -30.2% Dec 31, 2018
Q3 2018 662 -315 -32.3% Sep 30, 2018
Q2 2018 676 -353 -34.3% Jun 30, 2018
Q1 2018 683 -571 -45.6% Mar 31, 2018
Q4 2017 824 -589 -41.7% Dec 31, 2017
Q3 2017 977 -624 -39% Sep 30, 2017
Q2 2017 1.03K -1.08K -51.1% Jun 30, 2017
Q1 2017 1.25K -1.3K -51% Mar 31, 2017
Q4 2016 1.41K -953 -40.3% Dec 31, 2016
Q3 2016 1.6K -625 -28.1% Sep 30, 2016
Q2 2016 2.11K Jun 30, 2016
Q1 2016 2.56K Mar 31, 2016
Q4 2015 2.37K Dec 31, 2015
Q3 2015 2.23K Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.